Drawing for TUMORAD

USPTO serial 97828462

TUMORAD

Reviewed by CopyMark Law Group

Reg. 7518971Status 700Registered
Filing date
Status date
Registration date
Oct 1, 2024
Examiner
BHANOT, KAPIL KUMAR
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TUMORAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sana Hakim

Sana Hakim K&L GATES LLPP.O. BOX 1135CHICAGO, IL 60690-1135United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical or veterinary purposes; medical diagnostic reagents; x-ray contrast agents for medical purposes; radiological contrast substances for medical purposes; contrast media for use in medical imaging; anti-cancer preparations, namely, compounds for treating cancer; pharmaceutical preparations and products for the treatment of cancer; drug delivery agents in the form of nano-sized carriers that facilitate the delivery of pharmaceutical preparations, chemicals used in medicine and nanomedical applications, namely, chemical reagents for medical purposes and chemical preparations for pharmaceutical or medical purposes, namely, for treating cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 1, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 24, 2024DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Aug 24, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 7, 2024IUCNNOTICE OF ALLOWANCE CANCELLED—
Mar 7, 2024EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 5, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 9, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 9, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 20, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 6, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 6, 2023DOCKASSIGNED TO EXAMINER—
Mar 13, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 11, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance